ARID3A and neoplasm: Specifically, we clarified that the miR-29-5P/ARID3A axis constitutes a negative feedback loop, which modulates PD-L1 expression in DLBCL and leads to changes in CD8+ T cell activity, ultimately promoting the immune escape of tumor cells (Figure 8).